PMDAinspection / enforcement54% confidence
[IBENTO][IBENTO]PMDA-ATC GMP Inspection Seminar 2026 applications open
Source: PMDA
Why This Matters
Why this matters: sets a inspection / enforcement precedent in the same sub-indication (cardiology) as United Therapeutics.
Regulatory Analysis
PMDA document relevant to the signal.
Supporting Context
- Therapeutic area
- Pulmonary Arterial Hypertension · Prostacyclin Analog
- Sub-indication
- Hypertension
Related signal: FDA Accepts Supplement Application for Tyvaso (Treprostinil)